SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001126234-12-000056
Filing Date
2012-10-31
Accepted
2012-10-31 15:28:29
Documents
10
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q nlnk-20120930x10q.htm 10-Q 872842
2 CEO CERTIFICATION nlnk-20120930xex311.htm EX-31.1 11337
3 CFO CERTIFICATION nlnk-20120930xex312.htm EX-31.2 11476
4 SECTION 1350 CERTIFICATION nlnk-20120930xex321.htm EX-32.1 8582
  Complete submission text file 0001126234-12-000056.txt   3176456

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT nlnk-20120930.xml EX-101.INS 235625
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nlnk-20120930.xsd EX-101.SCH 26386
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nlnk-20120930_cal.xml EX-101.CAL 49628
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nlnk-20120930_def.xml EX-101.DEF 153009
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nlnk-20120930_lab.xml EX-101.LAB 361897
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nlnk-20120930_pre.xml EX-101.PRE 189547
Mailing Address 2503 SOUTH LOOP DRIVE SUITE 5100 AMES IA 50010
Business Address 2503 SOUTH LOOP DRIVE SUITE 5100 AMES IA 50010 515-296-5555
NEWLINK GENETICS CORP (Filer) CIK: 0001126234 (see all company filings)

IRS No.: 421491350 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35342 | Film No.: 121170701
SIC: 2834 Pharmaceutical Preparations